BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. MU
8. DFTX
9. HOOD
10. RGNX

Go back to BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update

Brainstorm Cell Therapeutics (BCLI) Tops Q3 EPS by 1c

November 17, 2015 7:18 AM EST

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15).

Third Quarter 2015 and Recent Highlights

Completed enrollment in Phase II, randomized, double-blind, placebo-controlled multicenter clinical trial of NurOwn® in ALS.Successful... More